Moderna's speedy COVID-19 vaccine results not possible alongside CMO, says CEO 19-May-2020 By Ben Hargreaves Moderna’s CEO comments on positive early results by highlighting the importance of its own manufacturing capabilities.
Immunai unveils map of human immune system 18-May-2020 By Jenni Spinner A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.
Thermo Fisher set to build $180m viral vector site 18-May-2020 By Ben Hargreaves The site will be responsible for commercial manufacturing and will double the company’s viral vector capacity.
Biotech launches to create ‘rationally’ designed gene therapy 14-May-2020 By Ben Hargreaves Kriya Therapeutics launches publicly after raising $80.5m in financing, with three gene therapies in the pipeline.
US strikes $138m deal to ensure enough syringes for COVID-19 vaccine 13-May-2020 By Ben Hargreaves US HHS provides funding in order to boost the number of prefilled syringes available for potential vaccine against coronavirus.
BMS spends $200m to buy bluebird out of CAR-T payments 12-May-2020 By Ben Hargreaves With the partners’ CAR-T therapy under review by the FDA, BMS chooses to purchase bluebird’s royalty rights and take control of ex-US manufacturing.
Pfizer to outsource brand products, making space for COVID-19 vaccine 12-May-2020 By Ben Hargreaves Pfizer looks to outsource more of its vaccine and intravenous drugs to free up capacity for potential COVID-19 vaccine.
Novavax receives record $388m funding for COVID-19 vaccine 12-May-2020 By Ben Hargreaves CEPI awards Novavax highest investment to date, with the biotech progressing candidate into trials and partners with Emergent for production.
Pfizer and BioNTech work to scale up COVID-19 vaccine production 11-May-2020 By Ben Hargreaves Pfizer identifies four facilities globally to produce vaccine, while BioNTech will increase production at its German facilities.
Regeneron devotes New York facility to COVID-19 cocktail treatment 11-May-2020 By Ben Hargreaves Regeneron expects an antibody cocktail against coronavirus to be ready for trials in June, plans to utilize entire facility for production.
Lonza and Moderna shoot for billion COVID-19 vaccine doses 05-May-2020 By Ben Hargreaves Moderna announces it has partnered with Lonza with the aim of producing one billion doses annually.
Ajinomoto to produce potential COVID-19 treatment for CytoDyn 05-May-2020 By Ben Hargreaves Ajinomoto agrees partnership to manufacture leronlimab, which is currently undergoing clinical trials for the treatment of COVID-19.
Pfizer’s $308m buy-in for Lyme disease vaccine 04-May-2020 By Ben Hargreaves Pfizer partners with Valneva to progress Phase II-stage vaccine candidate for Lyme disease.
COVID-19 vaccine in one year ‘wishful thinking’ 04-May-2020 By Ben Hargreaves The likelihood of an effective vaccine being developed and scaled up in less than 12 months is unrealistic, suggests GlobalData analyst.
Catalent takes on manufacture of J&J’s coronavirus vaccine 30-Apr-2020 By Ben Hargreaves Catalent announces partnership with J&J to manufacture lead COVID-19 vaccine candidate, plans to hire 300 staff and manufacture 24/7.
